Faces of Discovery: Kylie Gorringe
22 October 2025
Kylie Gorringe is a Associate Professor and Group Leader at Peter Mac. We find out why she chose her path, what inspires her every day, and the goals that keep her going in the lab, the clinic, and beyond.
What are you researching?
Understanding a rare ovarian cancer subtype and finding new treatments.
What motivated you to come and work at Peter Mac?
The ability to work in a place where clinicians and scientists work together to do great research.
What drives you to achieve better outcomes for cancer patients?
Talking to the fantastic consumers; I also get a lot of emails from patients and families asking for help with their rare cancer, which can be challenging emotionally but is highly motivating.
How will your research improve outcomes for cancer patients?
We are working on a neglected cancer type; our experiments use patient-derived models and we hope to find treatments that are specific for their disease, either new or drugs that already work in other cancer types that can be readily translated to the clinic.
What do you like most about working for Peter Mac?
The people.
Can you please detail how your research has used and benefitted from the core facilities at Peter Mac?
Cores are absolutely central - we do all our drug screening with the Victorian Centre for Functional Genomics, we have done a lot of sequencing with the genomics core, we use the animal facility, we couldn't do anything without lab services and we use the microscope and Fluorescence-activated cell sorter (FACS) facilities all the time.